U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention RSV Lower Respiratory Tract Disease in Infants
On Jun. 9, 2025, Merck announced the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA™ (clesrovimab-cfor) for…
Bird-flu vaccine for cattle aces early test
On May, 20, 2025, a team of scientists has developed a fresh approach: the first mRNA bird-flu vaccine…
USDA confirmed highly pathogenic Avian influenza in Tennessee
On Sept. 15, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
Mandatory masking in schools reduced COVID-19 cases during Delta surge
On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
Vanderbilt researchers discovered a new genetic disease
On Jan. 13, 2020, Vanderbilt University Medical Center researcher Ela Knapik, MD and her colleagues announced they had…
The University of Tennessee Institute of Agriculture was awarded a grant to study cattle genomics
On Dec. 2, 2019, the University of Tennessee Institute of Agriculture announced it had received a grant by…
FDA approved new sickle cell treatment based on clincal trial resutls from UTHSC’s Kenneth Ataga, MD
On Dec. 2, 2019, the U.S. Food and Drug Administration (FDA) announced it had approved the drug crizanlizumab…
Vanderbilt-Ingram Cancer Center (VICC) announced new role in international cancer database project, Project GENIE
On Nov. 7, 2019, the Vanderbilt-Ingram Cancer Center (VICC) announced its new role in the Project GENIE (Genomics…
UT Professor Elizabeth Derryberry was recognized as an important female ornithologist by the Cornell Lab of Ornithology
On Oct. 21, 2019, Elizabeth Derryberry, professor of ecology and evolutionary biology at the University of Tennessee (UT),…
Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA repair pathway
On Jul. 25, 2019, Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA…
Vanderbilt Vaccine Center Director James Crow Jr, MD, was awarded half of the Future Insight Prize by Merck KGaA of Germany
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease
On Apr. 18, 2019, St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease. By…
St Jude and World Health Organization announce a five-year collaboration to transform cancer care
On Sept. 27, 2018, St.ﾠJude Children’s Hospital and the World Health Organization announced a five-year collaboration to transform…
PMI BioPharma Solutions was founded
In 2018, PMI BioPharma Solutions was established in Nashville to offer a full range of research and development…
The Vanderbilt Microbiome Initiative was founded
In 2017, the Vanderbilt Microbiome Initiative (VMI) at Vanderbilt University was established bringing together an unprecedented group of…
New prostate cancer therapy investigated at Vanderbilt University Medical Center
On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
St. Jude Children’s Hospital launched the Pediatric Cancer Genome Project
On Jan. 25, 2010, St. Jude Children’s Research Hospital and Washington University School of Medicine launched a $65…
Lung oncology expert Alan Sandler, MD joined the Knight Cancer Institute
On Jan. 21, 2009, the Knight Cancer Institute announced the recruitment of lung oncology expert Alan Sandler, M.D.,…
St. ﾠJude Children’s Research Hospital received NCI comprehensive center designation
In 2008, the St.ﾠ Jude Children’s Research Hospital received National Cancer Institute (NCI) comprehensive center designation. St.ﾠJude Children’s…
The St Jude LIFE study on long-term effects of cancer and its treatment launched
In 2007, The St. Jude LIFE study on the long-term effects of cancer and its treatment began. This…
Vanderbilt Center for Neuroscience Drug Discovery was founded
In 2007, the Vanderbilt Center for Neuroscience Drug Discovery was established, combining the expertise of four groups of…
The Vanderbilt Institute of Chemical Biology (VICB) was founded
In 2002, the Vanderbilt Institute of Chemical Biology (VICB) was founded at the Vanderbilt School of Medicine to…
Vanderbilt-Ingram Cancer Center earned the NCI’s highest distinction as a Comprehensive Cancer Center
In 2001, the Vanderbilt-Ingram Cancer Center (VICC) earned the National Cancer Institute’s (NCI) highest distinction as a Comprehensive…
The Tennessee Biotechnology Association was established
On Apr. 15, 1999, the Tennessee Biotechnology Association (TBA), now the Life Science Tennessee, was established. The Tennessee…
St Jude Immunology chair Peter Doherty was awarded the Nobel Prize for Physiology or Medicine
In 1996, the Nobel Prize in Physiology or Medicine 1996 was awarded jointly to St. Jude’s Peter C….
Vanderbilt Cancer Center was established
In 1993, the Vanderbilt Cancer Center was established under the leadership of Dr. Hal Moses, to bring together…
Dr. Stanley Cohen was awarded the Nobel Prize in 1986 for the co-discovery of epidermal growth factor
In 1986, Dr. Stanley Cohen of the Vanderbilt University School of Medicine and Dr. Rita Levi-Montalcini each received…
Stﾠ. Jude Children’s Hospital launched the After Completion of Therapy Clinic
In 1984, St. ﾠJude Children’s Hospital launched the After Completion of Therapy Clinic, the world’s largest long-term follow-up…